Latest News in the pharma Industry

Research & Development

Alvotech and DKSH extend biosimilar partnership in Asia

Alvotech and DKSH extend biosimilar partnership in Asia

22 Sep 2020

The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.

Read more 
Europital launches as a science-driven full-service CRO

Europital launches as a science-driven full-service CRO

22 Sep 2020

Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.

Read more 
Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis

Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis

22 Sep 2020

The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis.

Read more 
T-knife and Catalent sign tech transfer and manufacturing agreement

T-knife and Catalent sign tech transfer and manufacturing agreement

21 Sep 2020

Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021.

Read more 
Gilead Sciences agrees to buy Immunomedics in $21 billion deal

Gilead Sciences agrees to buy Immunomedics in $21 billion deal

16 Sep 2020

Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer.

Read more 
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

15 Sep 2020

Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.

Read more 
Evotec and Bioaster partner to build technology and innovation hub in Lyon

Evotec and Bioaster partner to build technology and innovation hub in Lyon

14 Sep 2020

Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies.

Read more 
Key trends boosting the post-pandemic CRO market

Key trends boosting the post-pandemic CRO market

8 Sep 2020

Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity.

Read more 
INOVIO signs up Thermo Fisher to support COVID-19 vaccine production

INOVIO signs up Thermo Fisher to support COVID-19 vaccine production

8 Sep 2020

The CDMO will support INOVIO's plans to have 100 million doses of COVID-19 vaccine candidate INO-4800 manufactured in 2021.

Read more 
Exelixis and Catalent collaborate to develop antibody-drug conjugates

Exelixis and Catalent collaborate to develop antibody-drug conjugates

8 Sep 2020

The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.

Read more 
AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US

AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US

2 Sep 2020

Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19.

Read more 
New syringe technology could make the 'uninjectable' injectable

New syringe technology could make the 'uninjectable' injectable

25 Aug 2020

Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.

Read more